Multi-algorithms analysis for pre-treatment prediction of response to transarterial chemoembolization in hepatocellular carcinoma on multiphase MRI
Open Access
- 28 February 2023
- journal article
- research article
- Published by Springer Science and Business Media LLC in Insights into Imaging
- Vol. 14 (1), 1-12
- https://doi.org/10.1186/s13244-023-01380-2
Abstract
This study compared the accuracy of predicting transarterial chemoembolization (TACE) outcomes for hepatocellular carcinoma (HCC) patients in the four different classifiers, and comprehensive models were constructed to improve predictive performance. The subjects recruited for this study were HCC patients who had received TACE treatment from April 2016 to June 2021. All participants underwent enhanced MRI scans before and after intervention, and pertinent clinical information was collected. Registry data for the 144 patients were randomly assigned to training and test datasets. The robustness of the trained models was verified by another independent external validation set of 28 HCC patients. The following classifiers were employed in the radiomics experiment: machine learning classifiers k-nearest neighbor (KNN), support vector machine (SVM), the least absolute shrinkage and selection operator (Lasso), and deep learning classifier deep neural network (DNN). DNN and Lasso models were comparable in the training set, while DNN performed better in the test set and the external validation set. The CD model (Clinical & DNN merged model) achieved an AUC of 0.974 (95% CI: 0.951–0.998) in the training set, superior to other models whose AUCs varied from 0.637 to 0.943 (p < 0.05). The CD model generalized well on the test set (AUC = 0.831) and external validation set (AUC = 0.735). DNN model performs better than other classifiers in predicting TACE response. Integrating with clinically significant factors, the CD model may be valuable in pre-treatment counseling of HCC patients who may benefit the most from TACE intervention.Keywords
Funding Information
- National Key Research and Development projects intergovernmental cooperation in science and technology of China (2018YFE0126900)
- National Natural Science Foundation of China (82102162, 82072026)
- Natural Science Foundation of Zhejiang Province (LGF21H180002)
- Zhejiang Provincial Key Laboratory of Wood Science and Technology (2022RC087)
This publication has 40 references indexed in Scilit:
- Retreatment with TACE: The ABCR SCORE, an aid to the decision-making processJournal of Hepatology, 2015
- Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolizationJournal of Hepatology, 2015
- Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature reviewChinese Journal of Cancer, 2014
- Treatment of hepatocellular carcinoma in Child-Pugh B patientsDigestive and Liver Disease, 2013
- Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomasJournal of Hepatology, 2011
- Regression Shrinkage and Selection via The Lasso: A RetrospectiveJournal of the Royal Statistical Society Series B: Statistical Methodology, 2011
- Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall SurvivalRadiology, 2011
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaJournal of Hepatology, 2002
- Support-vector networksMachine Learning, 1995